A new survey is looking at hormone therapy patient experiences, to help gather evidence for an intended application to NICE for a new oral hormone treatment. The survey has two parts, 60 and 20 minutes respectively, and participants will be paid for their time. The initiative is recommended by TACKLE Prostate Cancer, the national body of which PCaSO is a member. Contact engagement@just-worldwide.com for further details.